Anavex Life Sciences
World Rank (Jan-05-2024)
12,167
Market Cap (Jan-05-2024)
0.536 Billion USD
World Rank (Jul-30-2023)
11,175
Market Cap (Jul-30-2023)
0.641 Billion USD
World Rank (Dec-25-2022)
10,700
Market Cap (Dec-25-2022)
0.659 Billion USD
World Rank (Jan-07-2022)
8,577
Market Cap (Jan-07-2022)
1.18 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-48 Million USD
Annual Results for Period Ending
Sep-2022 ending year
Company Profile
Anavex Life Sciences is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS treatments. The headquarters is in USA.
Company Website